The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer
Open accessAbstract
Purpose: Because of its rarity, male breast cancer is often compared with female breast cancer. Patients and Methods: To compare and contrast male and female breast cancers, we obtained case and population data from the National Cancer Institute's Surveillance, Epidemiology, and End Results program for breast cancers diagnosed from 1973 through 2005. Standard descriptive epidemiology was supplemented with age-period-cohort models and breast cancer survival analyses. Results: Of all breast cancers, men with breast cancer make up less than 1%. Male compared with female breast cancers occurred later in life with higher stage, lower grade, and more estrogen receptor–positive tumors. Recent breast cancer incidence and mortality rates declined over time for men and women, but these trends were greater for women than for men. Comparing patients diagnosed from 1996 through 2005 versus 1976 through 1985, and adjusting for age, stage, and grade, cause-specific hazard rates for breast cancer death declined by 28% among men (P = .03) and by 42% among women (P ≈ 0). Conclusion: There were three intriguing results. Age-specific incidence patterns showed that the biology of male breast cancer resembled that of late-onset female breast cancer. Similar breast cancer incidence trends among men and women suggested that there are common breast cancer risk factors that affect both sexes, especially estrogen receptor–positive breast cancer. Finally, breast cancer mortality and survival rates have improved significantly over time for both male and female breast cancer, but progress for men has lagged behind that for women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Permutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 982
Models for temporal variation in cancer rates. II: Age–period–cohort models
Clayton, D., & Schifflers, E. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060406 · Cited by 916
Kim, H. (2001) · Statistics in Medicine · doi:10.1002/sim.811 · Cited by 873
Breast carcinoma in men: A population‐based study
Giordano, S. H., Cohen, D. S., Buzdar, A. U., Perkins, G., & Hortobagyi, G. N. (2004) · Cancer · doi:10.1002/cncr.20312 · Cited by 789
Fentiman, I. S., Fourquet, A., & Hortobagyi, G. N. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68226-3 · Cited by 744
Models for temporal variation in cancer rates. I: Age–period and age–cohort models
Clayton, D., & Schifflers, E. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060405 · Cited by 685
The Estimation of Age, Period and Cohort Effects for Vital Rates
Holford, T. R. (1983) · Biometrics · doi:10.2307/2531004 · Cited by 603
Multiplicative Models and Cohort Analysis
Breslow, N. E., Lubin, J. H., Marek, P., & Langholz, B. (1983) · Journal of the American Statistical Association · doi:10.1080/01621459.1983.10477915 · Cited by 565
(1999) · Choice Reviews Online · doi:10.5860/choice.36-3094 · Cited by 560
Giordano, S. H., Buzdar, A. U., & Hortobagyi, G. N. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-8-200210150-00013 · Cited by 490
Holford, T. (2005) · Encyclopedia of Biostatistics · doi:10.1002/0470011815.b2a03003 · Cited by 405
Sasco, A. J., Lowenfels, A. B., & Jong, P. C. M. P.-D. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530403 · Cited by 397
Sørlie, T., Wang, Y., Xiao, C., Johnsen, H., Naume, B., Samaha, R. R., & Børresen-Dale, A.-L. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-127 · Cited by 387
Effect of Screening and Adjuvant Therapy on Mortality From Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000201966.23445.91 · Cited by 386
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.
Friedman, L. S., Gayther, S. A., Kurosaki, T., Gordon, D., Noble, B., Casey, G., Ponder, B. A. J., & Anton‐Culver, H. (1997) · PubMed · Cited by 275
Prevalence of Klinefelter's syndrome in male breast cancer patients.
Hultborn, R., Hanson, C., Köpf, I., Verbiené, I., Warnhammar, E., & WEIMARCK, A. (1998) · PubMed · Cited by 218
Jatoi, I., Chen, B. E., Anderson, W. F., & Rosenberg, P. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2106 · Cited by 211
Self-citationAdjuvant systemic therapy for male breast carcinoma
Giordano, S. H., Perkins, G. H., Broglio, K., Garcia, S. G., Middleton, L. P., Buzdar, A. U., & Hortobagyi, G. N. (2005) · Cancer · doi:10.1002/cncr.21526 · Cited by 200
BRCA1 and BRCA2 mutations in a population-based study of male breast cancer
Basham, V. M., Lipscombe, J. M., Ward, J. M., Gayther, S. A., Ponder, B. A., Easton, D. F., & Pharoah, P. D. (2001) · Breast Cancer Research · doi:10.1186/bcr419 · Cited by 191
Moredo Anelli, T. F., Anelli, A., Tran, K. N., Lebwohl, D. E., & Borgen, P. I. (1994) · Cancer · doi:10.1002/1097-0142(19940701)74:1<74::aid-cncr2820740113>3.0.co;2-# · Cited by 180
Adjuvant Tamoxifen for male breast cancer (MBC)
Ribeiro, G., & Swindell, R. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.50 · Cited by 179
Comparison of Age Distribution Patterns for Different Histopathologic Types of Breast Carcinoma
Anderson, W. F., Pfeiffer, R. M., Dores, G. M., & Sherman, M. E. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0191 · Cited by 163
Self-citationGraphical Presentation of Trends in Rates
Devesa, S. S., Donaldson, J., & Fears, T. (1995) · American Journal of Epidemiology · doi:10.1093/aje/141.4.300 · Cited by 159
Mariotto, A. B. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.21.1626 · Cited by 151
Male breast cancer: is the scenario changing
Contractor, K. B., Kaur, K., Rodrigues, G. S., Kulkarni, D. M., & Singhal, H. (2008) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-6-58 · Cited by 127
Thomas, D. B. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036108 · Cited by 108
Age-related crossover in breast cancer incidence rates between black and white ethnic groups
Anderson, W. F., Rosenberg, P. S., Menashe, I., Mitani, A., & Pfeiffer, R. M. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn411 · Cited by 98
Self-citationStages at presentation, prognostic factors, and outcome of breast cancer in males
Vetto, J. T., Jun, S.-Y., Padduch, D., Eppich, H., & Shih, R. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00067-7 · Cited by 70
Incidence of male breast cancer in scandinavia, 1943–1982
Ewertz, M., Holmberg, L., Karjalainen, S., Tretli, S., & Adami, H. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430107 · Cited by 68
Premenopausal and Postmenopausal Breast Cancer: One Disease or Two?
de Waard, F. (1979) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/63.3.549 · Cited by 64
Understanding and management of male breast cancer: a critical review
Pant, K., & Dutta, U. (2007) · Medical Oncology · doi:10.1007/s12032-007-9034-y · Cited by 45
Breast Cancer Trends: A Marriage Between Clinical Trial Evidence and Epidemiology
Berry, D. A., & Ravdin, P. M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm080 · Cited by 21
19. MALE BREAST CANCER: AETIOLOGY, GENETICS AND CLINICAL MANAGEMENT
Tischkowitz, M. D., Hodgson, S. V., & Is, F. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11371.x · Cited by 19
English, J. C., Middleton, C., Patterson, J. W., & Slingluff, C. L. (2000) · International Journal of Dermatology · doi:10.1046/j.1365-4362.2000.00007.x · Cited by 14
Cited by
A Web Tool for Age–Period–Cohort Analysis of Cancer Incidence and Mortality Rates
Rosenberg, P. S., Check, D. P., & Anderson, W. F. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0300 · Cited by 819
Self-citationCardoso, F., Bartlett, J. M. S., Slaets, L., van Deurzen, C. H. M., van Leeuwen-Stok, E., Porter, P., Linderholm, B., Hedenfalk, I., Schröder, C., Martens, J., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdx651 · Cited by 405
An Overview of PARP Inhibitors for the Treatment of Breast Cancer
Cortesi, L., Rugo, H. S., & Jackisch, C. (2021) · Targeted Oncology · doi:10.1007/s11523-021-00796-4 · Cited by 393
Male breast cancer: a disease distinct from female breast cancer
Gucalp, A., Traina, T. A., Eisner, J. R., Parker, J. S., Selitsky, S. R., Park, B. H., Elias, A. D., Baskin-Bey, E. S., & Cardoso, F. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4921-9 · Cited by 392
Giordano, S. H. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1707939 · Cited by 390
Metadata
- Authors
- Anderson, W. F., Jatoi, I., Tse, J., & Rosenberg, P. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2010-01-10
- Volume
- 28
- Issue
- 2
- Pages
- 232-239
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2141926802
- Cited by
- 495
- References
- 40
- FWCI
- 15.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.